REGN

The current price of Regeneron Pharmaceuticals Inc (REGN) is 807.71. Over the past 24 hours, the stock has changed by -0.87%. Follow the REGN chart for real-time price dynamics.

Regeneron Pharmaceuticals Inc trades under the ticker REGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

REGN has changed by -2.58% over the last week, +15.49% over the last month, and +39.95% over the last year. Review the chart to see whether the current move is part of a broader trend.

Regeneron Pharmaceuticals Inc currently has a market capitalization of 83.16 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Yes. You can track Regeneron Pharmaceuticals Inc financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

Last quarter, Regeneron Pharmaceuticals Inc reported earnings of 12.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

Regeneron Pharmaceuticals Inc reported quarterly revenue of 4.29 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

Regeneron Pharmaceuticals Inc reported net income of 1.3 B for the last quarter. The previous quarter showed 727.2 M, which means net income changed by +78.34%.

Regeneron Pharmaceuticals Inc paid a dividend per share of 0.94. The current dividend yield is 0.58%. Dividend data can help income-focused investors evaluate the stock.

Regeneron Pharmaceuticals Inc currently has a dividend yield of 0.58%. Previously, the dividend yield was 0.46%, compared with 0.46% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.

As of the latest available data, Regeneron Pharmaceuticals Inc has 15.41 K employees. Workforce size can provide additional context about the company's scale and operations.

Regeneron Pharmaceuticals Inc EBITDA is 1.42 B, and its EBITDA margin is 33.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

You can buy Regeneron Pharmaceuticals Inc (REGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Investing in Regeneron Pharmaceuticals Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the REGN chart and related analysis on metatrader.com as part of your research.